Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended		12 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (4,467,125)	$ (6,240,215)	$ (7,832,970)
Adjustment to reconcile net loss to net cash (used in) operating activities
Change in derivative liabilities	2,524,671	4,804,260
Interest expense from derivative instruments	456,750	356,715
Loss from sale of fixed assets, net	0	14,606
Employee stock option expense	60,054	47,211	65,744
Amortization of prepaid compensation	34,583	0
Provision for doubtful accounts	(4,830)	126,763	(58,234)
Depreciation and amortization	174,436	540,783
Changes in operating assets and liabilities
Accounts receivable	(46,819)	(134,757)
Prepaid expenses	(6,032)	(10,029)
Other assets	(409)	(17,004)
Accounts payable and accrued expenses	410,815	452,712
Patent settlement liability	(192,527)	(133,557)
Deferred revenue	(83,604)	(103,145)
Net cash (used in) operating activities	(1,140,037)	(295,657)
CASH FLOWS FROM INVESTING ACTIVITIES
Proceeds from sale of property and equipment	0	50,000
Purchase of property and equipment	(107,844)	(108,698)
Net cash (used in) investing activities	(107,844)	(58,698)
CASH FLOWS FROM FINANCING ACTIVITIES
Repayments of notes payable	0	(131,800)
Proceeds from revolving line of credit	800,000	0
Net cash provided by/(used in) financing activities	800,000	(131,800)
Effect of exchange rate changes on cash and cash equivalents	(30,485)	(10,586)
Net decrease in cash and cash equivalent	(478,366)	(496,741)
Cash and cash equivalents at beginning of period	873,315	1,302,287	1,302,287
Cash and cash equivalents at end of period	394,949	805,546	873,315
Supplemental disclosures of cash flow information:
Income taxes	48,599	54,699
Interest	725,546	1,242,079
Non-cash transactions
Notes payable issued in exchange for existing notes payable	2,866,879	0
Promissory Notes Issued for Accrued Interest [Member]
Non-cash transactions
Promissory notes issued for accrued interest	$ 529,000	$ 0